Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial

This publication has 31 references indexed in Scilit:

• Results of European post-marketing surveillance of bosentan in pulmonary hypertension
  European Respiratory Journal, 2007
• Bosentan Therapy in Patients With Eisenmenger Syndrome
  Circulation, 2006
• Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension
  European Heart Journal, 2006
• Treatment of Pulmonary Arterial Hypertension With the Selective Endothelin-A Receptor Antagonist Sitaxsentan
  Published by Elsevier ,2006
• Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2
  European Respiratory Journal, 2004
• Clinical efficacy of sildenafil in primary pulmonary hypertension
  Journal of the American College of Cardiology, 2004
• Survival in Primary Pulmonary Hypertension
  Circulation, 2002
• Inhaled Iloprost for Severe Pulmonary Hypertension
  New England Journal of Medicine, 2002
• Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study
  The Lancet, 2001
• Multiple Testings: Multiple Comparisons and Multiple Endpoints
  Drug Information Journal, 1998